← Back to Search

Light Therapy

Blue light phototherapy for Grover's Disease

N/A
Waitlist Available
Led By Shuai Xu
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up time frame: 1 year
Awards & highlights
No Placebo-Only Group

Summary

This trial will use a special blue light to treat people with psoriasis vulgaris and Grover's Disease. The blue light helps reduce skin inflammation and makes skin cells grow more normally. This treatment is aimed at improving skin conditions for these patients. Blue light has been shown to be effective in treating psoriasis and other skin conditions by reducing inflammation and promoting normal skin cell growth.

Eligible Conditions
  • Grover's Disease
  • Plaque Psoriasis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~time frame: 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and time frame: 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Assess User Experience With the Dermatology Life Quality Index (DLQI) Pre and Post-treatment.
Efficacy of Blue Light Therapy for Patients With Grover's Disease
Secondary study objectives
Cellular analysis of Blue light phototherapy

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Adult treatment armExperimental Treatment1 Intervention
Adults enrolled in the study will receive treatment (blue light phototherapy) on one area of their body affected by psoriasis or Grover's disease. The treatment area (restricted by size of the device) will be compared to untreated areas affected by disease on the same patient.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Blue light phototherapy
2020
N/A
~20

Find a Location

Who is running the clinical trial?

T-Cellerate LLCUNKNOWN
Northwestern UniversityLead Sponsor
1,645 Previous Clinical Trials
958,583 Total Patients Enrolled
Shuai XuPrincipal InvestigatorNorthwestern University
6 Previous Clinical Trials
296 Total Patients Enrolled
~2 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top